Characterisation of five missense mutations in the cystathionine beta-synthase gene from three patients with B6-nonresponsive homocystinuria.
Homocystinuria, due to a deficiency of the enzyme cystathionine beta-synthase (CBS), is an inborn error of sulphur-amino acid metabolism. This is an autosomal recessive disease which results in hyperhomocysteinaemia and a wide range of clinical features, including optic lens dislocation, mental retardation, skeletal abnormalities and premature thrombotic events. We report the identification of 5 missense mutations in the protein-coding region of the CBS gene from 3 patients with pyridoxine-nonresponsive homocystinuria. Reverse-transcription PCR was used to amplify CBS cDNA from each patient and the coding region was analysed by direct sequencing. The mutations detected included 3 novel (1058C-->T, 992C-->A and 1316G-->A) and 2 previously identified (430G-->A and 833C-->T) base alterations in the CBS cDNA. Each of these mutations predicts a single amino acid substitution in the CBS polypeptide. Appropriate cassettes of patient CBS cDNA, containing each of the above defined mutations, were used to replace the corresponding cassettes of normal CBS cDNA sequence within the bacterial expression vector pT7-7. These recombinant mutant and normal CBS constructs were expressed in Escherichia coli cells and the catalytic activities of the mutant proteins were compared with normal. All of the mutant proteins exhibited decreased catalytic activity in vitro, which confirmed the association between the individual mutation and CBS dysfunction in each patient.
Dawson
P A
PA
Department of Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
Cox
A J
AJ
Emmerson
B T
BT
Dudman
N P
NP
Kraus
J P
JP
Gordon
R B
RB
D000293:Adolescent; D015153:Blotting, Western; D002648:Child; D003541:Cystathionine beta-Synthase / Q000172:deficiency / Q000235:genetics*; D004252:DNA Mutational Analysis; D005260:Female; D006710:Homocysteine / Q000032:analysis; D006712:Homocystinuria / Q000235:genetics* / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010375:Pedigree; D016133:Polymerase Chain Reaction; D011736:Pyridoxine / Q000627:therapeutic use; D015183:Restriction Mapping
D006710:Homocysteine; D003541:Cystathionine beta-Synthase; D011736:Pyridoxine